[go: up one dir, main page]

NO20012301D0 - Ny fremgangsmåte for behandling - Google Patents

Ny fremgangsmåte for behandling

Info

Publication number
NO20012301D0
NO20012301D0 NO20012301A NO20012301A NO20012301D0 NO 20012301 D0 NO20012301 D0 NO 20012301D0 NO 20012301 A NO20012301 A NO 20012301A NO 20012301 A NO20012301 A NO 20012301A NO 20012301 D0 NO20012301 D0 NO 20012301D0
Authority
NO
Norway
Prior art keywords
treatment
new procedure
procedure
new
Prior art date
Application number
NO20012301A
Other languages
English (en)
Other versions
NO20012301L (no
NO328391B1 (no
Inventor
Lisa Benincosa
William Jusko
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012301(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20012301D0 publication Critical patent/NO20012301D0/no
Publication of NO20012301L publication Critical patent/NO20012301L/no
Publication of NO328391B1 publication Critical patent/NO328391B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20012301A 1998-11-12 2001-05-10 Farmasoytisk preparat med forlenget frigjoring og anvendelse derav NO328391B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824893.3A GB9824893D0 (en) 1998-11-12 1998-11-12 Novel method of treatment
PCT/US1999/026746 WO2000027341A2 (en) 1998-11-12 1999-11-12 Novel method of treatment

Publications (3)

Publication Number Publication Date
NO20012301D0 true NO20012301D0 (no) 2001-05-10
NO20012301L NO20012301L (no) 2001-07-09
NO328391B1 NO328391B1 (no) 2010-02-08

Family

ID=10842389

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012301A NO328391B1 (no) 1998-11-12 2001-05-10 Farmasoytisk preparat med forlenget frigjoring og anvendelse derav

Country Status (40)

Country Link
EP (2) EP1135128B1 (no)
JP (1) JP2003521455A (no)
KR (2) KR20070048279A (no)
CN (3) CN1235586C (no)
AP (2) AP2005003432A0 (no)
AR (2) AR029149A1 (no)
AT (1) ATE366573T1 (no)
AU (1) AU768303B2 (no)
BG (2) BG110061A (no)
BR (1) BR9915284A (no)
CA (1) CA2350425C (no)
CO (1) CO5150158A1 (no)
CY (1) CY1106892T1 (no)
CZ (1) CZ299801B6 (no)
DE (1) DE69936533T2 (no)
DK (1) DK1135128T3 (no)
DZ (1) DZ2938A1 (no)
EA (2) EA009192B1 (no)
ES (1) ES2289833T3 (no)
GB (1) GB9824893D0 (no)
HK (1) HK1041202B (no)
HR (1) HRP20010344B1 (no)
HU (1) HUP0104262A3 (no)
IL (1) IL143088A0 (no)
MA (1) MA26759A1 (no)
MY (1) MY128347A (no)
NO (1) NO328391B1 (no)
NZ (1) NZ527132A (no)
OA (1) OA12193A (no)
PE (1) PE20001239A1 (no)
PL (1) PL349421A1 (no)
PT (1) PT1135128E (no)
RS (1) RS50130B (no)
SK (1) SK286357B6 (no)
TR (1) TR200101348T2 (no)
TW (1) TWI234456B (no)
UA (1) UA79730C2 (no)
UY (2) UY25797A1 (no)
WO (1) WO2000027341A2 (no)
ZA (1) ZA200103793B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
JP2005514399A (ja) * 2001-12-21 2005-05-19 スミスクライン ビーチャム コーポレーション PPARγアクチベーターの投薬法
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH0469331A (ja) * 1990-07-10 1992-03-04 Asahi Chem Ind Co Ltd 徐放性エマルジョン製剤
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
US5478853A (en) * 1992-10-12 1995-12-26 Adir Et Compagnie Thazolidinedione compounds
CA2115587A1 (en) * 1993-02-18 1994-08-19 Hayato Kihara Styrene copolymers, polystyrene compositions, processes for producing styrene copolymers, and injection-molded articles
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
RU2195282C2 (ru) * 1993-09-15 2002-12-27 Санкио Компани Лимитед Применение тиазолидиндионов для предотвращения или отдаления наступления инсулиннезависимого сахарного диабета (niddm)
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
DZ2938A1 (fr) 2004-03-15
CO5150158A1 (es) 2002-04-29
HRP20010344A2 (en) 2002-06-30
NO20012301L (no) 2001-07-09
AU768303B2 (en) 2003-12-04
DE69936533D1 (de) 2007-08-23
YU37401A (sh) 2005-07-19
KR20010080440A (ko) 2001-08-22
KR20070048279A (ko) 2007-05-08
CN1771943A (zh) 2006-05-17
DK1135128T3 (da) 2007-11-05
EP1135128A4 (en) 2003-07-16
CN1354661A (zh) 2002-06-19
RS50130B (sr) 2009-03-25
NZ527132A (en) 2005-01-28
EP1135128B1 (en) 2007-07-11
CZ20011656A3 (cs) 2002-06-12
WO2000027341A2 (en) 2000-05-18
ATE366573T1 (de) 2007-08-15
AR029149A1 (es) 2003-06-18
CA2350425C (en) 2009-06-02
CY1106892T1 (el) 2012-01-25
IL143088A0 (en) 2002-11-10
TR200101348T2 (tr) 2002-02-21
SK6422001A3 (en) 2001-12-03
SK286357B6 (sk) 2008-08-05
ZA200103793B (en) 2002-06-05
HRP20010344B1 (en) 2008-02-29
PL349421A1 (en) 2002-07-29
EP1135128A2 (en) 2001-09-26
NO328391B1 (no) 2010-02-08
CN1235586C (zh) 2006-01-11
JP2003521455A (ja) 2003-07-15
UA79730C2 (en) 2007-07-25
HUP0104262A3 (en) 2003-06-30
EA009192B1 (ru) 2007-12-28
MA26759A1 (fr) 2004-12-20
HUP0104262A2 (en) 2002-08-28
PT1135128E (pt) 2007-10-12
AR029317A1 (es) 2003-06-25
MY128347A (en) 2007-01-31
BR9915284A (pt) 2002-02-13
EA200100539A1 (ru) 2001-12-24
BG110061A (bg) 2008-12-30
HK1041202B (en) 2007-10-05
OA12193A (en) 2006-05-09
WO2000027341A3 (en) 2000-09-08
EP1759698A1 (en) 2007-03-07
EA200700968A1 (ru) 2008-06-30
UY25801A1 (es) 2000-08-21
CZ299801B6 (cs) 2008-11-26
PE20001239A1 (es) 2000-12-24
GB9824893D0 (en) 1999-01-06
AP1580A (en) 2006-02-24
BG65577B1 (bg) 2009-01-30
DE69936533T2 (de) 2008-03-13
TWI234456B (en) 2005-06-21
UY25797A1 (es) 2000-12-29
HK1041202A1 (en) 2002-07-05
AU1719600A (en) 2000-05-29
BG105569A (en) 2002-01-31
ES2289833T3 (es) 2008-02-01
CA2350425A1 (en) 2000-05-18
CN101244062A (zh) 2008-08-20
AP2005003432A0 (en) 2005-12-31

Similar Documents

Publication Publication Date Title
NO20001870D0 (no) Ny fremgangsmõte for behandling
DE69938817D1 (de) Erstellungsverfahren
NO20005503L (no) Ny anvendelse
ID27841A (id) Turunan-turunan biaril terapeutik
ID30025A (id) Metode perlakuan tekstil
DE69929047D1 (de) Haarbehandlungsmittel
DE59913141D1 (de) Blutbehandlungsgerät
NO991944D0 (no) Ny forbindelse
DE59905321D1 (de) Haarnachbehandlungsmittel
DE69921571D1 (de) Massagegerät
NO20003996D0 (no) Ny forbindelse
NO20005179D0 (no) Medikament behandling
ID17723A (id) Senyawa untuk pengobatan
NO993298L (no) Ny fremgangsmÕte
DE69908232D1 (de) Laserbehandlungsvorrichtung
ID27483A (id) Metoda terapi gen
DE69907803D1 (de) Laserbehandlungsgerät
NO20013337D0 (no) Ny behandling
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS4789A (is) Meðferðarefnasambönd
NO995796L (no) Ny fremgangsmåte
NO20012301D0 (no) Ny fremgangsmåte for behandling
DE59805361D1 (de) Sterilisierbehälter
FI982722A0 (fi) Diagnostinen menetelmä
ATA208398A (de) Handstück

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees